Glucocorticoid-induced osteoporosis: Assessment and treatment

Journal of Clinical Densitometry

Volumn 1, Issue 1, 1998, Pages 65-73

  Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cushing syndrome; Glucocorticoid; Latrogenic

Indexed keywords

EID: 0003160309     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:1:1:65     Document Type: Review

References (41)

1. Cooper C, Coupland C, Mitchell M. 1995 Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 54:49-52.
2. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. 1997 Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol. 24:1489-1494.
3. LoCascio V, Bonucci E, Imbimbo B, et al. 1990 Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 8:39-51.
4. Laan RFJM, Vanriel PLCM, Vandeputte LBA, Vanerning LJTO, Vanthof MA, Lemmens JAM. 1993 Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis - a randomized, controlled study. Ann Intern Med. 119:963-968.
5. Saito JK, Davis JW, Wasnich RD, Ross PD. 1995 Users of low-dose glucocorticoids have increased bone loss rates: A longitudinal study. Calcif Tissue Int. 57:115-119.
6. Reid IR, Heap SW. 1990 Determinants of vertebral mineral density in patients receiving chronic glucocorticoid therapy. Arch Int Med. 150:2545-2548.
7. Hall GM, Spector TD, Griffin AJ, Jawad ASM, Hall ML, Doyle DV. 1993 The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum. 36:1510-1516.
8. Mateo L, Nolla JM, Rozadilla A, Rodriguezmoreno J, Niubo R, Valverde J, Roigescofet D. 1993 Bone mineral density in patients with temporal arteritis and polymyalgia rheumatica. J Rheumatol. 20:1369-1373.
9. Reid IR, Evans MC, Wattie DJ, Ames R, Cundy TF. 1992 Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients. Osteoporos Int. 2:103-105.
10. Reid IR, Evans MC, Stapleton J. 1992 Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res. 7:1221-1225.
11. Finkelstein JS, Cleary RL, Butler JP, et al. 1994 A comparison of lateral versus anterior-posterior spine dual energy x-ray absorptiometry for the diagnosis of osteopenia. J Clin Endocrinol Metab. 78:724-730.
12. Blanckaert F, Cortet B, Coquerelle P, Flipo RM, Duquesnoy B, Marchandise X, Delcambre B. 1997 Contribution of calcaneal ultrasonic assessment to the evaluation of postmenopausal and glucocorticoid-induced osteoporosis. Revue du Rhumatisme. 64:305-313.
13. Reid IR, Chapman GE, FraserTR, et al. 1986 Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J Clin Endocrinol Metab. 62:379-383.
14. Mayo-Smith W, Rosenthal DI, Goodsitt MM, Klibanski A. 1989 Intravertebral fat measurement with quantitative CT in patients with Cushing disease and anorexia nervosa. Radiology. 170:835-838.
15. Lo Cascio V, Bonucci E, Imbimbo B, et al. 1990 Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 8:39-51.
16. Rizzato G, Montemurro L. 1993 Reversibility of exogenous corticosteroid-induced bone loss. Eur Resp J. 6:116-119.
17. Lane SJ, Vaja S, Swaminathan R, Lee TH. 1996 Effects of prednisolone on bone turnover in patients with corticosteroid resistant asthma. Clin Experiment Allergy. 26:1197-1201.
18. Doull I, Freezer N, Holgate S. 1996 Osteocalcin, growth, and inhaled corticosteroids - a prospective study. Arch Dis Child. 74:497-501.
19. Cumming RG, Mitchell P, Leeder SR. 1997 Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 337:8-14.
20. Lufkin EG, Wahner HW, Bergstralh EJ. 1988 Reversibility of steroid-induced osteoporosis. Am J Med. 85:887-888.
21. Hermus AR, Smals AG, Swinkels LM, et al. 1995 Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab. 80:2859-2865.
22. Manning PJ, Evans MC, Reid IR. 1992 Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol. 36:229-234.
23. Gluck OS, Murphy WA, Hahn TJ, Hahn B. 1981 Bone loss in adults receiving alternate day glucocorticoid therapy. Arthritis Rheum. 24:892-898.
24. Ruegsegger P, Medici TC, Anliker M. 1983 Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol. 25:615-620.
25. Dempster DW. 1989 Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res. 4:137-141.
26. Reid IR. 1997 Glucocorticoid osteoporosis -mechanisms and management. Eur J Endocrinology. 137:209-217.
27. Reid IR, King AR, Alexander CJ, Ibbertson HK. 1988 Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet, i: 143-146.
28. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J. 1993 Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 328:1747-1752.
29. Reid IR, Ibbertson HK. 1986 Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr. 44:287-290.
30. Nilsen KH, Jayson MIV, Dixon AStJ. 1978 Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients: A controlled study. BMJ. ii:1124.
31. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. 1996 Calcium and vitamin D-3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis - a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 125:961-968.
32. Adachi JD, Bensen WG, Bianchi F, et al. 1996 Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis - a 3 year followup. J Rheumatol. 23:995-1000.
33. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. 1979 Altered mineral metabolism in glucocorticoid-induced osteopenia. J Clin Invest. 64:655-665.
34. Di Munno O, Beghe F, Favini P, Di Giuseppe P, Pontrandolfo A, Occhipinti G, Pasero G. 1989 Prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin D and calcium. Clin Rheumatol. 8:202-207.
35. Gallacher SJ, Fenner JAK, Anderson K, et al. 1992 Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease - an open pilot study. Thorax. 47:932-936.
36. Adachi JD, Bensen WG, Brown J, et al. 1997 Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 337:382-387.
37. Reid IR, France JT, Pybus J, Ibbertson HK. 1985 Low plasma testosterone levels in glucocorticoid-treated male asthmatics. BMJ. 291:574.
38. Reid IR, Wattie DJ, Evans MC, Stapleton JP. 1996 Testosterone therapy in glucocorticoid-treated men. Arch Int Med. 156:1173-1177.
39. Grey AB, Cundy TF, Reid IR. 1994 Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis. Clin Endocrinol. 40:671-677.
40. Rizzoli R, Chevalley T, Slosman DO, Bonjour JP. 1995 Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis. Osteoporos Int. 5:39-46.
41. Adachi JD, Bensen WG, Bell MJ, et al. 1997 Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. Br J Rheumatol. 36:255-259.